Xu, Jie

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine

COVID-19 Clinical Research StudiesRespiratory Support and Mechanisms

Cited by 8,249

Gain of function of mutant p53 by coaggregation with multiple tumor suppressors

Xu, J., Reumers, J., Couceiro, J. R., De Smet, F., Gallardo, R., Rudyak, S., Cornelis, A., Rozenski, J., Zwolinska, A., Marine, J.-C., et al. (2011) · Nature Chemical Biology

Cancer-related Molecular PathwaysHeat shock proteins research

Cited by 543

Identification of Alzheimer's disease–associated long noncoding RNAs

Zhou, X., & Xu, J. (2015) · Neurobiology of Aging

Cancer-related molecular mechanisms researchAlzheimer's disease research and treatments

Cited by 102

Rise of PD-L1 expression during metastasis of colorectal cancer: Implications for immunotherapy

Wang, H. B., Yao, H., Li, C. S., Liang, L. X., Zhang, Y., Chen, Y. X., Fang, J., & Xu, J. (2017) · Journal of Digestive Diseases

Cancer Immunotherapy and BiomarkersColorectal Cancer Treatments and Studies

Cited by 100

TMEFF2 inhibits pancreatic cancer cells proliferation, migration, and invasion by suppressing phosphorylation of the MAPK signaling pathway

Han, H., Zhan, Z., Xu, J., & Song, Z. (2019) · OncoTargets and Therapy

Pancreatic and Hepatic Oncology ResearchMechanisms of cancer metastasis

Cited by 21

Proteasomal and lysosomal degradation for specific and durable suppression of immunotherapeutic targets

Wang, Y., Deng, S., & Xu, J. (2020) · Cancer Biology and Medicine

Protein Degradation and InhibitorsCancer Immunotherapy and Biomarkers

Cited by 10